Evidence map›Paper›PMID 25667263›Full record

ArticleInfection and immunity2015

Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Kara J Levinson, Magdia De Jesus, Nicholas J Mantis

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Systemic, Mucosal, and Memory Immune Responses following Cholera.Tropical medicine and infectious disease · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Passive Immunity toPathogens & immunity · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kara J LevinsonDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA Department of Biomedical Sciences, University at Albany, Albany, New York, USA.
Magdia De JesusDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Nicholas J MantisDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA Department of Biomedical Sciences, University at Albany, Albany, New York, USA Nicholas.Mantis@health.ny.gov.ORCID http://orcid.org/0000-0002-5083-8640
New York State Department of Health · US

Funding

Intestinal P450 and Xenobiotic MetabolismR01GM082978 · NIGMS · WADSWORTH CENTER · PI ZHANG, QING-YU · 2008 to 2018
$3.3M
Training in Biodefense and Emerging Infectious DiseaseT32AI055429 · NIAID · WADSWORTH CENTER · PI MCDONOUGH, KATHLEEN A · 2004 to 2014
$2.2M
Epithelial Glycoconjugates as Barriers against Enteric InfectionsR01HD061916 · NICHD · WADSWORTH CENTER · PI BRY, LYNN, MANTIS, NICHOLAS J. · 2009 to 2013
$1.9M
Howard Hughes Medical InstituteNIAID NIH HHS 5T32AI055429-08NIAID NIH HHS T32 AI055429NICHD NIH HHS HD061916NICHD NIH HHS R01 HD061916NIGMS NIH HHS GM082978NIGMS NIH HHS R01 GM082978
6 · The paper itself

Abstract

2D6 is a dimeric monoclonal immunoglobulin A (IgA) specific for the nonreducing terminal residue of Ogawa O-polysaccharide (OPS) of Vibrio cholerae. It was previously demonstrated that 2D6 IgA is sufficient to passively protect suckling mice from oral challenge with virulent V. cholerae O395. In this study, we sought to define the mechanism by which 2D6 IgA antibody protects the intestinal epithelium from V. cholerae infection. In a mouse ligated-ileal-loop assay, 2D6 IgA promoted V. cholerae agglutination in the intestinal lumen and limited the ability of the bacteria to associate with the epithelium, particularly within the crypt regions. In vitro fluorescence digital video microscopy analysis of antibody-treated V. cholerae in liquid medium revealed that 2D6 IgA not only induced the rapid (5- to 10-min) onset of agglutination but was an equally potent inhibitor of bacterial motility. Scanning electron microscopy showed that 2D6 IgA promoted flagellum-flagellum cross-linking, as well as flagellar entanglement with bacterial bodies, suggesting that motility arrest may be a consequence of flagellar tethering. However, monovalent 2D6 Fab fragments also inhibited V. cholerae motility, demonstrating that antibody-mediated agglutination and motility arrest are separate phenomena. While 2D6 IgA is neither bactericidal nor bacteriostatic, exposure of V. cholerae to 2D6 IgA (or Fab fragments) resulted in a 5-fold increase in surface-associated blebs, as well an onset of a wrinkled surface morphotype. We propose that the protective immunity conferred by 2D6 IgA is the result of multifactorial effects on V. cholerae, including agglutination, motility arrest, and possibly outer membrane stress.

Indexed as

AgglutinationAnimalsAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialBacterial AdhesionCholeraFemaleFlagellaImmunoglobulin AImmunoglobulin Fab FragmentsIntestinal MucosaMiceMice, Inbred BALB CPolysaccharides, BacterialVibrio choleraeAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialImmunoglobulin AImmunoglobulin Fab FragmentsPolysaccharides, Bacterial

Identifiers

PMID25667263
PMCPMC4363435
OpenAlexW2160133830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.